Requests for brand name over generic prescription drugs cost the Medicare program $1.7 billion in a single year
Skipping mammogram increases risk of death from breast cancer
2 March 2021U.S. to monitor air travelers from African nations with Ebola
2 March 2021Requests for brand name over generic prescription drugs cost the Medicare program $1.7 billion in a single year
The Medicare Part D program would have saved $977 million in a single year if all branded prescription drugs requested by prescribing clinicians had been substituted by a generic option, according to a new study by researchers at the Johns Hopkins Bloomberg School of Public Health. And if Medicare patients had requested generic drugs instead of brand name drugs, the Medicare Part D program would have saved an additional $673 million in one year, for a total savings of $1.7 billion.
